In hepatocellular carcinoma, overexpression of GNAI1 significantly reduced metastatic capability by interfering with the RhoA-ROCK signaling pathway, a known regulator of cytoskeletal remodeling and cell motility [20]. The gene discussed is RHOA; the disease is hepatocellular carcinoma.